Multiple sclerosis.
Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O.
Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23.
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.
Kalincik T.
Neuroepidemiology. 2015;44(4):199-214. doi: 10.1159/000382130. Epub 2015 May 20.
[Relapsing-Remitting Multiple Sclerosis].
Niino M, Miyazaki Y.
Brain Nerve. 2021 May;73(5):442-449. doi: 10.11477/mf.1416201784.
Abnormal multisensory integration in relapsing-remitting multiple sclerosis.
Giurgola S, Casati C, Stampatori C, Perucca L, Mattioli F, Vallar G, Bolognini N.
Exp Brain Res. 2022 Mar;240(3):953-968. doi: 10.1007/s00221-022-06310-0. Epub 2022 Jan 30.
Facts and myths about aggressive relapsing-remitting multiple sclerosis - current state of knowledge and future perspectives.
Dyczkowska K, Kalinowska A.
Neurol Neurochir Pol. 2024;58(6):548-556. doi: 10.5603/pjnns.103636.
Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
Hu Y, Nie H, Yu HH, Qin C, Wu LJ, Tang ZP, Tian DS.
Autoimmun Rev. 2019 May;18(5):542-548. doi: 10.1016/j.autrev.2019.03.011. Epub 2019 Mar 4.
Executive functions in relapsing-remitting multiple sclerosis.
Elosúa MR, Villadangos N.
Appl Neuropsychol Adult. 2025 Jul-Aug;32(4):944-952. doi: 10.1080/23279095.2023.2252125. Epub 2023 Nov 6.
Relapsing-remitting multiple sclerosis: an interpretative phenomenological analysis of dyadic dynamics.
Wawrziczny E, Corrairie A, Antoine P.
Disabil Rehabil. 2021 Jan;43(1):76-84. doi: 10.1080/09638288.2019.1617794. Epub 2019 May 26.
Are There General Features of How Immune Responses Are Regulated That Can Provide Clues to How Remitting/Relapsing Multiple Sclerosis May Be Treated?
Bretscher PA.
Int J Mol Sci. 2024 Feb 27;25(5):2726. doi: 10.3390/ijms25052726.
Immunomodulatory therapies for relapsing-remitting multiple sclerosis: monoclonal antibodies, currently approved and in testing.
Craddock J, Markovic-Plese S.
Expert Rev Clin Pharmacol. 2015 May;8(3):283-96. doi: 10.1586/17512433.2015.1036030.
